Companies /Healthcare

Transmedics Group Inc

NASDAQ: TMDX Medical Devices
$93.24
â–² $1.02 (+1.10%) today
Markets open · 1:28pm ET
Today · % change

Fundamentals

Market Cap
$3.2B
P/E Ratio
24.3
Profit Margin
22.7%
Revenue (TTM)
$668.5M
EPS (TTM)
$3.80
52-Week Range
$60 – $156
Street Target
$97.30

About TransMedics Group

TransMedics Group, Inc. is a pioneering medical technology company based in Andover, Massachusetts, focused on enhancing organ transplant processes. It has developed the Organ Care System (OCS), an innovative portable system for the perfusion, optimization, and monitoring of donor organs outside the human body, mimicking near-physiologic conditions. This technology supports the preservation of lungs, hearts, and livers from donors, aiming to improve transplant outcomes. TransMedics also offers comprehensive organ management and logistics services, streamlining the transplant process for healthcare providers around the globe.

TMDX Coverage